Benefits
Helps reduce menopausal hot flashes (standardized form)
Standardized rhapontic rhubarb root extract has been shown in placebo-controlled trials of perimenopausal women to reduce the frequency and severity of hot flashes and night sweats over 12 weeks; most rigorous data are tied to the standardized ERr 731 form rather than generic rhubarb extracts.
Supports overall menopausal symptom relief
Daily use of standardized rhapontic rhubarb extract is associated with improvements in composite menopausal symptom scores covering vasomotor, psychological, and somatic complaints, supporting comfort during the perimenopausal transition without reliance on hormone therapy.
Helps maintain mood and emotional balance
Clinical trial data with standardized rhapontic rhubarb suggest improvements in subscales relating to anxiety, irritability, and depressed mood in perimenopausal women, helping support emotional well-being during fluctuating hormones.
Provides non-estrogenic hormonal support
As a selective estrogen receptor beta-preferring botanical, rhapontic rhubarb hydroxystilbenes offer menopausal symptom support without measurable activation of estrogen receptor alpha in standard assays, distinguishing it from classical estrogenic preparations.
Mechanism of action
Selective estrogen receptor beta activation
The aglycones rhapontigenin and desoxyrhapontigenin preferentially bind and transactivate estrogen receptor beta in cellular reporter assays while showing essentially no transactivation of estrogen receptor alpha, mimicking the receptor profile thought to mediate central menopausal symptom relief.
Modulation of hypothalamic thermoregulation
Estrogen receptor beta activation in hypothalamic neurons is implicated in stabilizing the thermoregulatory set point, providing a hypothesized mechanism by which rhapontic rhubarb hydroxystilbenes reduce hot flash frequency and night sweats in perimenopause.
Lack of uterotrophic estrogen receptor alpha signaling
Because rhapontic rhubarb hydroxystilbenes do not transactivate estrogen receptor alpha, preclinical and clinical safety data show no endometrial thickening or proliferation, distinguishing the botanical from classical estrogen-containing menopause therapies.
Clinical trials
Multicenter, randomized, double-blind, placebo-controlled trial of one enteric-coated standardized rhapontic rhubarb tablet (ERr 731) daily for 12 weeks (Heger et al., Menopause).
109 perimenopausal women with climacteric complaints.
Standardized rhapontic rhubarb extract produced significantly greater reductions in Menopause Rating Scale II total score and in individual hot flash and somatic subscales versus placebo. Was rated effective and well tolerated, with no estrogenic endometrial effects observed.
Multicenter, randomized, double-blind, placebo-controlled confirmatory trial of standardized rhapontic rhubarb root extract (ERr 731) for 12 weeks (Kaszkin-Bettag et al., Alternative Therapies in Health and Medicine).
112 perimenopausal women with menopausal symptoms.
Confirmatory trial replicated significant reductions in Menopause Rating Scale total score and in hot flash frequency and severity versus placebo over 12 weeks, with good tolerability. Strengthens evidence that the standardized rhapontic rhubarb form is effective in perimenopausal symptom relief.